Skip to content

Clinical trials

alpha 1-Antitrypsin Deficiency trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20171
20192
20211
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Terminated3
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arrowhead Pharmaceuticals2
Kamada, Ltd.2
AIRNA Corporation1
Beam Therapeutics Inc.1
Canisius-Wilhelmina Hospital1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Grifols Therapeutics LLC1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency10
Emphysema4
Genetic Diseases, Inborn2
Lung Diseases2
Pathologic Processes2
Pulmonary Disease, Chronic Obstructive2
Respiratory Tract Diseases2
Subcutaneous Emphysema2
Aneurysm1
Congenital Abnormalities1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.